A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/1992
12/23/1992	EP0519819A1 Composition for use to reduce hair loss and to induce and stimulate its growth, containing derivatives of 2,4,6-triaminopyrimidin-N-oxide and the new derivatives of 2,4,6-triaminopyrimidin-N-oxide
12/23/1992	EP0519353A2 Indolizin derivatives, process for their preparation and pharmaceutical composition containing them
12/22/1992	US5172481 Electronic inclinometer
12/22/1992	CA1311757C Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity
12/21/1992	CA2071802A1 Composition for slowing the rate of falling hair and inducing and stimulating hair growth, containing pyrimidines n-oxyde trisubstituted in 2,4 and 6 with an amine functionality or their sulfoconjugated derivatives, novel pyri idines n-oxyde compounds or their sulfoconjugated derivatives
12/17/1992	DE4119170A1 Synergistic compsn. for treating neuro-dermatitis - comprises triamcinolone acetonide, salicylic acid or its acetyl deriv., and coal tar extract
12/16/1992	EP0518722A1 Dithiane substituted retinoides, their use, process of their preparation, cosmetic and pharmaceutical compositions containing them and their use in therapeutics
12/16/1992	EP0517836A1 Method and product for promoting hair growth and treating skin conditions
12/16/1992	EP0517797A1 Use of vitamin-d analogues in the treatment of acne.
12/16/1992	CN1067057A Process for preparing unsaturated 17 -substituted 3-carboxysteroids
12/15/1992	US5170567 Electronic inclinometer
12/10/1992	WO1992021695A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	WO1992021669A1 2-phenylbenzo[b]furans and thiophenes, methods of preparing them and pharmaceutical preparations containing them
12/10/1992	WO1992021643A1 Azulenic retinoid compounds, compositions and methods
12/10/1992	WO1992021354A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
12/10/1992	WO1992021338A1 Medetomidine preparations for transdermal administration
12/10/1992	WO1992021334A1 Pharmaceutical compositions containing 4-substituted imidazoles to be administered transdermally
12/10/1992	WO1992021322A1 Cosmetic or pharmaceutical, particularly dermatological, composition containing a prunella extract
12/10/1992	WO1992021321A1 Method for separating a vegetable compound
12/10/1992	CA2110158A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	CA2110062A1 2-phenylbenzo[b]furans, processes for their manufacture and pharmaceutical preparations containing them
12/10/1992	CA2109707A1 Vegetal coumpound extraction process
12/09/1992	EP0517047A1 Unsaturated 17beta-substituted 3-carboxy steroids
12/09/1992	CN1066790A Non-porous collagen sheet for therapeutic use, and method and apparatus for preparing it
12/08/1992	US5169840 Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
12/08/1992	US5169630 Containing superoxide dismutase
12/02/1992	EP0516257A1 Phenylbenzo[b]furans and -thiophenes, procedures for their preparation, and pharmaceutical compositions containing the same
12/02/1992	EP0516194A2 Pharmaceutical compositions containing cationic surfactants
12/02/1992	EP0516069A1 Leukotriene B4 antagonist
12/02/1992	EP0515517A1 Treatment of pruritis with esters and amides
12/01/1992	US5167958 Culture products of Streptomyces resistomycificus
12/01/1992	CA2069667A1 Leukotriene b4 antagonist
11/1992
11/26/1992	WO1992020664A1 A process for preparing 4-isothiazolin-3-one
11/26/1992	WO1992020646A1 Novel quaternary ammonium salts, process for obtaining same and pharmaceutical compositions containing them
11/26/1992	WO1992020643A1 Novel bi-aromatic compounds derived from a salicilic pattern, method of preparation and use in human and veterinary medecine and in cosmetics
11/26/1992	WO1992020354A1 Composition and method of treating depigmentation disorders
11/26/1992	WO1992020341A1 Method and composition for ameliorating the adverse effects of aging
11/26/1992	WO1992020340A1 Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
11/26/1992	WO1992020322A1 Cosmetic or pharmaceutical, particularly dermatological composition, intended to enhance the pigmentation of the skin or hair, containing a cyperus extract and production process
11/26/1992	WO1992017065A3 Method of inhibiting fibrosis
11/26/1992	CA2102514A1 Composition and method of treating depigmentation disorders
11/25/1992	WO1992020700A1 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS
11/25/1992	EP0515312A2 Pharmaceutical composition containing terbinafine as an anti-mycotic agent
11/25/1992	EP0515310A1 Topical composition of terbinafine
11/25/1992	EP0515071A2 O-aryl, O-alkyl, O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
11/25/1992	EP0514970A1 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers
11/25/1992	EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use
11/25/1992	EP0514691A2 Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it
11/25/1992	EP0514553A1 Antipruritic drug and antipruritic composition
11/25/1992	EP0514375A1 Composition for the treatment of oily or greasy skin secretions
11/25/1992	CA2087953A1 Unsaturated 17.beta. -substituted 3-carboxy steroids
11/25/1992	CA2069222A1 Process and arrangement for treating hair and the skins of the head and/or body
11/25/1992	CA2069027A1 Pharmaceutical composition for topical use for the healing and reepithelization of chronic phlebostatic ulcers
11/24/1992	US5166170 2-(aminoaryl) indoles and indolines as topical antiinflammatory agents for the treatment of skin disorders
11/24/1992	US5166161 Antiallergens or antiinflammatory agents
11/24/1992	US5165932 Therapeutical compositions against psoriasis
11/23/1992	CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use
11/19/1992	EP0514367A2 Protein C-containing drug
11/19/1992	EP0514269A1 Imino-derivatives, process for their preparation and their use in human and veterinary medicine and in cosmetics
11/19/1992	EP0514264A1 Biaromatic compounds derived from compounds having a salicylic configuration, their preparation process and their use in human and veterinary medicine and in cosmetics
11/19/1992	EP0513997A1 Antithrombotic compositions
11/19/1992	EP0513878A2 Pharmaceutical compositions containing cationic surfactants
11/19/1992	EP0513862A2 Use of topical applicable preparation for treating skin aging
11/19/1992	EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
11/19/1992	EP0513671A1 Commiphora mukul extracts and therapeutical applications thereof
11/19/1992	EP0513201A1 Leukocyte-derived growth factor
11/19/1992	EP0513104A1 USE OF AN -g(a)-TOCOPHEROL PHOSPHATE OR A DERIVATIVE THEREOF FOR PREPARING COSMETIC, DERMATOLOGICAL OR PHARMACEUTICAL COMPOSITIONS, AND COMPOSITIONS THEREBY OBTAINED.
11/19/1992	DE4116123A1 Skin diseases treatment agent - contains 2-hydroxy-5-methyl-lauro-phenone oxime combined with natural hydrating agents, moisturisers and/or penetration promoters
11/17/1992	US5164373 Blodd-coagulation factor XIII
11/17/1992	US5164372 Treatment of respiratory disorders, inflammation, dermatitis
11/17/1992	US5164370 Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
11/17/1992	US5164367 Method of using copper(ii) containing compounds to accelerate wound healing
11/17/1992	US5164185 Side effect reduction
11/17/1992	US5164182 Skin lightening, antiinflammatory, cosmetics
11/17/1992	CA1310270C Pharmaceutical preparation for percutaneous administration containing eperisone or tolperisone or salt thereof
11/16/1992	CA2068696A1 Imine-derived aromatic compounds, process for their preparation and their use in human and veterinary medecine, and in cosmetics
11/14/1992	CA2068561A1 O-aryl, o-alkyl, o-alkenyl and o-alkynylmacrolides having immunosuppressive activity
11/12/1992	WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
11/12/1992	WO1992019602A1 Novel pyridazines
11/12/1992	WO1992019224A2 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative
11/12/1992	WO1992017426A3 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity
11/12/1992	CA2108029A1 Glycam-1(sgp 50), a selectin ligand
11/11/1992	WO1992020851A1 Sewing machine needle and method of manufacturing same
11/11/1992	EP0512095A1 Methyl pyrrolidinone chitosan, production process and uses thereof.
11/11/1992	EP0409862B1 Topical preparations
11/11/1992	CN1066062A Pharmaceutical compound
11/11/1992	CN1066060A Pharmaceutical compound
11/10/1992	US5162430 To a synthetic hydrophilic polymer, polyoxyethylene glycol; wound healing, slow release drug delivery
11/05/1992	DE4214328A1 New phosphinate-contg. peptide derivs. - as collagenase inhibitors e.g. for treating gangrene or dental infections
11/04/1992	CN1065865A Indole and dihydroquinoline potassium channel openers
11/04/1992	CN1018924B Process for preparing copolymers of vinyl alcohol with embedded glutaric aldehyde and vinyl acetic-ester
11/03/1992	CA1309658C Pharmaceutical compositions for treatment of hyperproliferate skin disease
11/02/1992	WO1992019230A1 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide
11/02/1992	CA2107780A1 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide
10/1992
10/28/1992	EP0511118A1 Use of lysine and or arginine pyrrolidone carboxylate as anti-oxydant agent in a cosmetic or pharmaceutical composition
10/28/1992	EP0511033A1 Extracts of the common lady's mantle, their preparation and their applications
10/28/1992	EP0510948A1 N-Hydroxy ureae as 5-lipoxygenase inhibitors
10/28/1992	EP0510947A1 N-Hydroxy (thio)ureas as 5-lipoxygenase inhibitors
10/28/1992	EP0510662A1 bFGF mutein and its production
10/28/1992	EP0510562A1 Pyridazines

1 ... 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 ... 1065